Fact CheckerSign in

NCT05996783Active, not recruiting

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

Source: ClinicalTrials.gov · Last updated 13 Jun 2025

Brief summary (registry, in English)

The goal of the ScreenUrSelf trial is to increase cervical cancer screening attendance and compliance to follow-up by offering a first-void urine self-sampling alternative to women who are currently not participating in the organized cervical cancer screening program (defined in this project as un(der)-screened women), either on the woman or her physician's personal initiative, or by responding on the invitation letter.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
48000 (estimated)
First submitted
2 Aug 2023
Start date
25 May 2023
Primary completion date
31 Mar 2024
Lead sponsor
Universiteit Antwerpen
NCT number
NCT05996783

What you commit to

  • Study type: Interventional
  • Planned participants: 48000
  • From 25 May 2023 to the primary completion date, 31 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Being pregnant or 6 weeks postpartum (self-reported after receiving the study letter/package)

Other

  • Participation during menstruation or within the 3 following days is a contraindication
  • Not able to understand the study materials and participation form (informed consent form)

Who the study is looking for

  • Eligible for cervical cancer screening within the organized Population-based Screening Program in Flanders:
    • Female
    • Residing in Flanders, Belgium
    • Not actively opted out of the organized cervical cancer screening program
    • No history of total hysterectomy (data available since 2002)
    • No (former) diagnosis of cervical or uterine cancer (data available as of 2008)
    • Not included in other CvKO pilot projects
  • No cervical result registered in the cytohistopathological register of BCR and no information in the administrative data from health insurance companies (IMA) on PAP smears taken for at least the last 6 years (i.e., two screening rounds)
  • 31-64 years old (birth year 1959-1992)

Age in the registry: 31 years to 64 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universiteit Antwerpen
Coordinator of this site? Confirm its status
EdegemBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.